Novel Concept, 'Immune Dimming,' Explored in Rheumatoid Arthritis

(MedPage Today) -- LONDON--In yet another effort to repurpose oncology drugs for autoimmune disease, a researcher reported here that low doses of blinatumomab (Blincyto) given to patients with treatment-resistant rheumatoid arthritis (RA)...